Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma

mycosis fungoides, recurrent anaplastic large cell lymphoma, recurrent angioimmunoblastic t-cell lymphoma, recurrent enteropathy-associated t-cell lymphoma, recurrent hepatosplenic t-cell lymphoma, recurrent peripheral t-cell lymphoma, not otherwise specified, refractory anaplastic large cell lymphoma, refractory angioimmunoblastic t-cell lymphoma, refractory enteropathy-associated t-cell lymphoma, refractory hepatosplenic t-cell lymphoma, refractory peripheral t-cell lymphoma, not otherwise specified, interventional